Annual Revenue
N/A
31 December 2023
Summary:
Regulus Therapeutics annual revenue is not available.RGLS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
Regulus Therapeutics quarterly revenue is not available.RGLS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
Regulus Therapeutics TTM revenue is not available.RGLS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGLS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
RGLS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Regulus Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $10.01 M(+46.5%) | $5.00 M(0.0%) | $10.01 M(+99.2%) |
| Sept 2020 | - | $5.00 M(>+9900.0%) | $5.02 M(+8273.3%) |
| Mar 2020 | - | $6000.00(-66.7%) | $60.00 K(-99.1%) |
| Dec 2019 | $6.83 M(+9388.9%) | $18.00 K(0.0%) | $6.83 M(0.0%) |
| Sept 2019 | - | $18.00 K(0.0%) | $6.83 M(0.0%) |
| June 2019 | - | $18.00 K(-99.7%) | $6.83 M(0.0%) |
| Mar 2019 | - | $6.78 M(>+9900.0%) | $6.83 M(+9388.9%) |
| Dec 2018 | $72.00 K(0.0%) | $18.00 K(0.0%) | $72.00 K(0.0%) |
| Sept 2018 | - | $18.00 K(0.0%) | $72.00 K(0.0%) |
| June 2018 | - | $18.00 K(0.0%) | $72.00 K(0.0%) |
| Mar 2018 | - | $18.00 K(0.0%) | $72.00 K(0.0%) |
| Dec 2017 | $72.00 K(-94.0%) | $18.00 K(0.0%) | $72.00 K(0.0%) |
| Sept 2017 | - | $18.00 K(0.0%) | $72.00 K(-72.1%) |
| June 2017 | - | $18.00 K(0.0%) | $258.00 K(-64.3%) |
| Mar 2017 | - | $18.00 K(0.0%) | $723.00 K(-39.4%) |
| Dec 2016 | $1.19 M(-94.2%) | $18.00 K(-91.2%) | $1.19 M(-90.1%) |
| Sept 2016 | - | $204.00 K(-57.8%) | $12.04 M(-12.1%) |
| June 2016 | - | $483.00 K(-1.2%) | $13.70 M(-19.7%) |
| Mar 2016 | - | $489.00 K(-95.5%) | $17.05 M(-17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $20.76 M(+170.7%) | $10.86 M(+482.3%) | $20.76 M(+47.0%) |
| Sept 2015 | - | $1.86 M(-51.4%) | $14.12 M(+5.9%) |
| June 2015 | - | $3.83 M(-8.7%) | $13.34 M(+30.3%) |
| Mar 2015 | - | $4.20 M(-0.5%) | $10.24 M(+33.5%) |
| Dec 2014 | $7.67 M(-60.8%) | $4.22 M(+289.6%) | $7.67 M(-13.9%) |
| Sept 2014 | - | $1.08 M(+47.1%) | $8.90 M(-36.1%) |
| June 2014 | - | $736.00 K(-54.9%) | $13.94 M(-22.4%) |
| Mar 2014 | - | $1.63 M(-70.1%) | $17.96 M(-8.2%) |
| Dec 2013 | $19.57 M(+54.1%) | $5.45 M(-10.9%) | $19.57 M(+12.8%) |
| Sept 2013 | - | $6.12 M(+28.6%) | $17.35 M(+23.6%) |
| June 2013 | - | $4.76 M(+47.0%) | $14.04 M(+11.5%) |
| Mar 2013 | - | $3.24 M(0.0%) | $12.59 M(-0.8%) |
| Dec 2012 | $12.70 M(-7.9%) | $3.24 M(+15.3%) | $12.70 M(-1.0%) |
| Sept 2012 | - | $2.81 M(-15.1%) | $12.82 M(-7.2%) |
| June 2012 | - | $3.31 M(-1.0%) | $13.82 M(+31.5%) |
| Mar 2012 | - | $3.34 M(-0.6%) | $10.52 M(+46.6%) |
| Dec 2011 | $13.79 M(+60.3%) | $3.36 M(-11.7%) | $7.17 M(+88.3%) |
| Sept 2011 | - | $3.81 M | $3.81 M |
| Dec 2010 | $8.60 M | - | - |
FAQ
- What is the all time high annual revenue for Regulus Therapeutics?
- What is the all time high quarterly revenue for Regulus Therapeutics?
- What is the all time high TTM revenue for Regulus Therapeutics?
What is the all time high annual revenue for Regulus Therapeutics?
Regulus Therapeutics all-time high annual revenue is $20.76 M
What is the all time high quarterly revenue for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly revenue is $10.86 M
What is the all time high TTM revenue for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM revenue is $20.76 M